Comments: NY A03253 | 2021-2022 | General Assembly
Bill Title: Requires manufacturer of nonprescription blood glucose self-testing equipment, devices and supplies to submit to the New York State Board of Pharmacy a comprehensive list of designated suppliers and authorized distributors of nonprescription blood glucose self-testing equipment, devices and supplies; prohibits pharmacists from distributing nonprescription blood glucose self-testing equipment, devices, and supplies or seeking reimbursement therefor when the pharmacist knows or has reason to know that the equipment did not come through an authorized supplier or distributor.
Spectrum: Bipartisan Bill
Status: (Introduced - Dead) 2022-01-05 - referred to higher education [A03253 Detail]
Text: Latest bill text (Introduced) [HTML]
Spectrum: Bipartisan Bill
Status: (Introduced - Dead) 2022-01-05 - referred to higher education [A03253 Detail]
Text: Latest bill text (Introduced) [HTML]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2021 New York A03253 at this time. |